The pharmaceutical industry teme that the vaccine of the grip of the next invasive can be less effective

Related News

With the desperate efforts in the massive evacuation against Covid in Spain, the pharmaceutical industry has the power to think too in the antigen of the flu which tends to inoculate the population next winter. A vacancy that can be less effective than other years.

At the end of February, the World Health Organization (OMS) promotes the pharmaceutical companies that are currently in circulation. It’s part of these with which the industry develops the antigens that are inoculated the next winter.

This year, the flu virus has circulated less debit to the hygiene media and the impediments to the impediment to the Covid-19 pandemic, also high evacuation bag.

Hecho, in Spain he was detected, just now, 959 cases in front of the 173,939 of the past year. Inklusief ‘n nivel mundial gripal activity is maintained in more levels than expected for this era of the year.

Al has drastically reduced flu cases, the pharmaceutical industry is facing a problem: “The vaccine will have a lower probability of becoming effective against the flu that may occur. the near future “, he explained the sources of the sector to Invertia.

El desarrollo

The release of the flu vaccine for the temporary approach will be “equal to the other years”. As mentioned, the OMS is proportional to the finals of February in the months that are currently circulating. With them, the pharmaceuticals unravel what the antigen will inoculate during the next winter.

Specifically, the organization proportion of four cepas (of type A and of type B) which are, with all probability, circular during the next time. “Pueden ser una, dos o incluso combinations de las cepas identifadas”, han indexed fuentes del pharma pharmaceutical.

Cabe record that the vacuas of the flu “no boy perfect“Exactly because of the mutations in the virus. In addition to the fact that the effect does not reach 100% and is already around 60%.

A pesar de ello, from the pharmaceutical industry does not prevent sobresaltos in this feeling. Finally, the OMS, through its vigilance centers, “it is determined that what is circulating and, although it has had fewer cases this year, has not been detected virus”.

Generalized dissemination

La generalized distribution of the circulation of influenza virus has been observed at world level. In this case, its circulation is vigilant in all lands, now in special form in the northern hemisphere, since it is located at the time of stationary influenza.

At the moment, there is a great deal of level of activity activity, which could lead to the means of control and social distance that are in force in order to control the pandemic of Covid-19, if many other factors could have contributed.

From the Institute of Health Carlos III (ISCIII) explains that the sanitary crisis generated a disruption of medical attention and the ability to perform rehab in the European Region of the OMS which negatively affected the notification of epidemiological and virological data at the end of the 2019-20 period.

As in the news of the continuous pandemic, “the release dates presented by Deben interpret with cautela, especially in terms of stationary employers “, advierten.

.Source